Lv51
1250 积分 2024-07-10 加入
Targeting the Pathogenesis of IgA Nephropathy — A New Treatment Approach?
6天前
已完结
Disproportionality analyses of Tapinarof-related adverse events based on the FAERS database
21天前
已完结
Disproportionality analyses of Tapinarof-related adverse events based on the FAERS database
22天前
已完结
The TrialNet Natural History Study of the Development of Type 1 Diabetes: objectives, design, and initial results
23天前
已完结
The evolving landscape of targets for lipid lowering: from molecular mechanisms to translational implications
1个月前
已完结
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial
2个月前
已完结
Prevalence of Elevated Lipoprotein(a) and its Association With Subclinical Atherosclerosis in 2.9 Million Chinese Adults
2个月前
已完结
LDL-C–Related Cardiovascular Burden in China 2010 to 2030
2个月前
已完结
Elimination of High-grade Gliomas Through Induced Cytolysis, Elucidated by Two Patient Cases
2个月前
已完结
Factor B inhibitor iptacopan for the treatment of paroxysmal nocturnal hemoglobinuria
3个月前
已完结
皖公网安备34019202002308
